Agilent Technologies, Inc. - Diagnostics and Genomics SSXT LI CD GlasgowCancerCore, 480 A
The Agilent SureSelectXT Low Input Custom DNA Glasgow Cancer Core kit (part number 5191-6739) is designed for targeted enrichment and sequencing of specific genomic regions associated with cancer research. This kit enables the preparation of sequencing libraries from low input amounts of DNA, making it suitable for challenging samples such as those derived from formalin-fixed, paraffin-embedded (FFPE) tissues. The kit supports up to 480 reactions and is optimized for high sensitivity and reproducibility, facilitating comprehensive analysis of cancer-related genes using next-generation sequencing platforms.